Which way to trade Oncimmune Holdings (LON:ONC)?

Which way to trade Oncimmune Holdings (LON:ONC)?

Article image

As any reader of this is probably aware, shares in Oncimmune Holdings (LON:ONC) are currently trading close to a 52 week high, with the share price up by around 14.5% to 206 over the past week. On a one-month basis, the Oncimmune Holdings price has risen by 5.33%.

For investors holding the stock (or considering buying it), the question is: what now?

52-week highs are a popular market indicator. But research shows investors can be left wondering what to do when it happens when a 52-week high is hit. Here’s a primer on what the academic research says...

What happens when a share hits a new high?

52 week highs are always good news. But surprisingly, the prices of high performing shares can be slow to move when they publish positive earnings news.

Why is this? Research shows investors become cautious about bidding their high performing shares any higher – even if they deserve it. Psychologists call this anchoring. As humans, we tend to take our time when it comes to changing our opinions in the face of new information - even when it's good news.

This emotional tug-of-war often ends with the ‘new high’ stock drifting higher in price over the coming weeks and months. The upward trend is called “post earnings announcement drift”. As the news sinks in, momentum takes over and the price moves higher and higher, as fear of missing out sets in.

A look at Oncimmune Holdings’s StockReport could offer more insight into what’s driving the momentum in its share price - and whether that might continue. What we do know however is that statistically speaking, prices continue to rise after a new 52-week high is hit – which may be a reason to hold-fire on any immediate plans to sell.

As always, take a look at Oncimmune Holdings’s StockReport to find out more about what is driving its own momentum – and always do your own research before deciding to trade any security.


What does this mean for potential investors?

With Oncimmune Holdings trading close to a 52 week high, it’s possible that investors in the market are uncertain about where the price will move next. It's important to remember that momentum on its own is no guarantee of future returns.

To get a better idea about whether this trend will continue, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Oncimmune Holdings that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

Oncimmune Holdings's StockRank™

Momentum TrapHighly Speculative

Oncimmune Holdings's StockRank™

With a StockRank of 9, Oncimmune Holdings is in the bottom 9% of the 7,586 stocks we cover in Europe, according to our proprietary ranking system.

See the full StockReport

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.